Zevia's Q2 Beat Was Real-But at 1.1% Sales Growth, This Still Looks Like a Trap Stock

Zevia's Q2 beat improved the print, not the growth problem

Zevia beat on Q2 revenue, but 1.1% sales growth still leaves the stock in trap-stock territory. Q2 net sales reached $45 million, yet that was only a 1.1% year-over-year increase, and management is guiding to roughly the same pace next quarter with Q3 sales expected between $44 million and $46 million. A thin beat can spark a short-term pop, but it does not justify a lasting rerating if the growth scoreboard stays this weak.

The beat was real; the growth signal was not

The operational improvements were genuine. Gross Margin: 48.9% in Q2 2026, a 20 basis point increase from 48.7% in the prior year quarter, and Adjusted EBITDA: Approximately $0.5 million in Q2 2026. That suggests Zevia can still extract better pricing and tighter expense control from a flat base. The key issue is not whether management can run a cleaner quarter. It is whether current sales velocity is strong enough to support the story before investors lose patience.

Balance-sheet strength helps, but it does not solve demand

Zevia still has room to invest, with Cash and Cash Equivalents: Approximately $28.5 million at the end of the quarter, with an undrawn revolving credit line of $20 million. But capital alone does not create demand. Until sales accelerate or at least trend higher, this quarter looks more like stabilization than a reason for a major rerating.

Operational progress is real, but it is not enough on its own

That is why the operational progress here deserves credit, but not a growth-stock badge. Against a backdrop of just 1.1% year-on-year sales growth, management did a real job of cleaning up the quarter. The key question is whether that discipline can convert into durable demand across Zevia's soda, energy drinks, and organic tea platform in its diversified omni-channel network. If it does, the stock could rerate from its current size. If not, another tidy earnings print will likely fade.

Volume and cost control were the best signals

The clearest operating improvement was volume, not price. Sales Volumes were up 3.7% year on year. That matters because volume is a cleaner read on consumer trial and repeat purchase than price-driven revenue growth.

Cost control was real, too. Selling and marketing expenses were 29% of net sales, down from 30%, and selling expense fell to 17.9% from 19.4% thanks to warehousing and repackaging cost savings. For a low-growth beverage company, that is how operating leverage starts to build: lower cost to move each unit, tighter spending, and a cleaner path to profitability off a flat base.

The profit line was solid as well. Adjusted EPS: -$0.02 vs analyst estimates of -$0.03 (in line). Management was not just spending harder to manufacture momentum; it improved the quality of the quarter.

Why the cleaner quarter still fails the bigger test

Discipline helps the model, but it does not create demand by itself.

Marketing expense rose to Marketing Expense: $5 million, or 11.1% of net sales, compared to $4.7 million, or 10.6% of net sales in Q2 2025 to support new product rollout and the Cardi B partnership. That is constructive only if it leads to repeat purchases and broader adoption across Zevia's distributed across the U.S. and Canada through a diversified omni-channel network spanning food, drug, mass, natural, club, and e-commerce footprint.

Bulls can point to First Half Net Sales: $91.1 million, a 10.4% increase year-over-year and argue the underlying business is healthier than one sluggish second quarter suggests. Bears will counter that a cleaner income statement is not the same thing as a high-quality growth curve. The more balanced read is that management has improved execution, but the company still needs proof that those gains are translating into durable demand.

Zevia's next rerating path depends on singles-led trial and execution

At a Market Capitalization: $122.7 million, Zevia is small enough that one real growth lever can move the stock fast. It is also small enough that the market is unlikely to pay up for another clean expense quarter. The bull case now depends less on squeezing the P&L and more on proving that management can turn category opportunity into actual unit movement.

The singles channel is the clearest wedge

But bulls still have to respect the execution gap. Management explicitly flagged the need for improved in-store execution, and that remains the real filter now. If the singles rollout works, it should show up in broader adoption, better shelf presence, and a cleaner payoff from marketing spend.

What to watch next

The next quarter matters because Q3 2026 Net Sales Guidance: Expected between $44 million and $46 million, so another quarter of roughly flat sales will keep the debate stuck in the same place.

The setup improves if Zevia can pair Full Year 2026 Net Sales Guidance: Maintained at $170 million to $175 million, reflecting 7% growth at the midpoint with continued volume strength and tighter execution. Until that happens, this still looks more like a trading story than a clear buy-now opportunity.